S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
OTCMKTS:AYRWF

Ayr Wellness (AYRWF) Stock Price, News & Analysis

$2.38
+0.30 (+14.42%)
(As of 02/23/2024 ET)
Today's Range
$2.07
$2.41
50-Day Range
$1.57
$4.00
52-Week Range
$0.57
$4.09
Volume
329,243 shs
Average Volume
396,109 shs
Market Capitalization
$182.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.75

Ayr Wellness MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
57.6% Upside
$3.75 Price Target
Short Interest
Healthy
0.34% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.40mentions of Ayr Wellness in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.09) to ($0.87) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.87 out of 5 stars


AYRWF stock logo

About Ayr Wellness Stock (OTCMKTS:AYRWF)

Ayr Wellness Inc. operates as a vertically-integrated cannabis multi-state operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

AYRWF Stock Price History

AYRWF Stock News Headlines

Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN?
Financial giants have been injecting millions into the crypto market. The big players are going all in on crypto… but what are they gearing up for? There is a significant event on the horizon that will shape the future of Bitcoin—the upcoming Bitcoin halving event…We're revealing all the secrets behind the financial elite's bold moves in crypto during our LIVE, online event.
AYR Completes Previously Announced Plan of Arrangement
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN?
Financial giants have been injecting millions into the crypto market. The big players are going all in on crypto… but what are they gearing up for? There is a significant event on the horizon that will shape the future of Bitcoin—the upcoming Bitcoin halving event…We're revealing all the secrets behind the financial elite's bold moves in crypto during our LIVE, online event.
AYR Wellness Reports Third Quarter 2023 Results
AYR Wellness Reports Second Quarter 2023 Results
See More Headlines
Receive AYRWF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayr Wellness and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/17/2023
Today
2/23/2024
Next Earnings (Estimated)
3/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:AYRWF
Fax
N/A
Employees
2,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.75
High Stock Price Target
$3.75
Low Stock Price Target
$3.75
Potential Upside/Downside
+57.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-245,470,000.00
Pretax Margin
-38.90%

Debt

Sales & Book Value

Annual Sales
$465.62 million
Book Value
$12.93 per share

Miscellaneous

Free Float
70,394,000
Market Cap
$182.31 million
Optionable
Not Optionable
Beta
2.91
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Jonathan Everett Sandelman J.D. (Age 66)
    Founder & Executive Chairman
    Comp: $1.2M
  • Mr. David Goubert
    President & CEO
  • Mr. Brad Asher
    CFO & Secretary
  • Mr. James Robert Mendola
    Chief Business Dev. Officer, National Head of Wholesale & Purchasing and GM of Western Region
  • George Frank DeNardo
    Chief Operating Officer
  • Mr. Sarvesh Mathur
    Chief Technology Officer
  • Robert Vanisko
    Head of Corporate Communications
  • Jeff Finnerty
    Chief Marketing Officer
  • Ms. Anya Varga
    Chief People Officer
  • Paul Fisher
    Chief Commercial Officer














AYRWF Stock Analysis - Frequently Asked Questions

Should I buy or sell Ayr Wellness stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ayr Wellness in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AYRWF shares.
View AYRWF analyst ratings
or view top-rated stocks.

What is Ayr Wellness' stock price target for 2024?

2 equities research analysts have issued 1 year target prices for Ayr Wellness' stock. Their AYRWF share price targets range from $3.75 to $3.75. On average, they expect the company's stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 57.6% from the stock's current price.
View analysts price targets for AYRWF
or view top-rated stocks among Wall Street analysts.

How have AYRWF shares performed in 2024?

Ayr Wellness' stock was trading at $1.8029 at the beginning of the year. Since then, AYRWF stock has increased by 32.0% and is now trading at $2.38.
View the best growth stocks for 2024 here
.

When is Ayr Wellness' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Saturday, March 9th 2024.
View our AYRWF earnings forecast
.

How were Ayr Wellness' earnings last quarter?

Ayr Wellness Inc. (OTCMKTS:AYRWF) posted its quarterly earnings data on Thursday, August, 17th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.09. The company had revenue of $116.74 million for the quarter, compared to the consensus estimate of $121.15 million. Ayr Wellness had a negative trailing twelve-month return on equity of 11.29% and a negative net margin of 86.64%.

How do I buy shares of Ayr Wellness?

Shares of AYRWF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AYRWF) was last updated on 2/23/2024 by MarketBeat.com Staff